Comparative Efficacy Study of Titratable Versus Active Mandibular Advancement Splint in Sleep Apnea

NCT ID: NCT02112435

Last Updated: 2024-03-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-08-31

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sleep apnea is a common disorder that occurs in 3-10 % of the adult population. This disorder disrupts the architecture and quality of sleep. Continuous positive airway pressure (CPAP) therapy is the standard treatment, but in some cases, it can not be used (patient refusal or intolerance). In these cases, treatment with mandibular advancement devices can bring an improvement in symptoms. Therefore, this study aims to compare the effectiveness of titratable versus active mandibular advancement splints in standard care environment. This will be based on the global response, which includes the apnea-hypopnea index and compliance in severe apnea patients who refused or where intolerant to CPAP. Following their severe apnea diagnosis and the assessment on the feasibility of placing a mandibular advancement device, follow-up visits will be scheduled after 3 months of treatment involving clinical monitoring by a physician and a dentist.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Narval ORM ® or SomnoDent ®

Mandibular advancement splint (Narval ORM ® or SomnoDent ®)

Group Type ACTIVE_COMPARATOR

Narval ORM ® or SomnoDent ®

Intervention Type DEVICE

Mandibular advancement splint

Somnyx ®

Active mandibular advancement splint (Somnyx ®)

Group Type EXPERIMENTAL

Somnyx ®

Intervention Type DEVICE

Active mandibular advancement splint

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Somnyx ®

Active mandibular advancement splint

Intervention Type DEVICE

Narval ORM ® or SomnoDent ®

Mandibular advancement splint

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Active mandibular advancement appliance Oral appliance Mandibular advancement splint Mandibular advancement appliance Oral appliance Mandibular repositioning appliance Mandibular repositioning splint

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age between 18 and 65 years
* severe OSA confirmed by polysomnography (PSG) is: 30\> AHI\> 15 with severe daytime sleepiness - Epworth ≥ 10 or AHI\> 30
* patient in failure or refusal of CPAP treatment
* agree to participate and sign the consent form research
* speak and understand French without external assistance
* be in good health (no neurological or psychiatric syndrome).
* have a valid Social Security card (in France and Portugal only)

Exclusion Criteria

* contra-indicated dental/periodontal states for mandibular advancement splints, such as: 1) significant edentulism (less than 3 healthy teeth / quadrant), 2) generalized periodontitis or severe parodonthopathies, 3) severe disorders of the temporomandibular joint (TMJ), 4) less than 5 mm of maximal mandibular protrusion
* dental restorations in progress or planned in the next 6 months
* psychiatric and neuromuscular disorders
* untreated cardiovascular diseases and history of stroke or myocardial infarction
* severe or morbid obesity (body mass index\> 35)
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Groupe Hospitalier Pitie-Salpetriere

OTHER

Sponsor Role collaborator

University Hospital, Montpellier

OTHER

Sponsor Role collaborator

Université de Montréal

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nelly Huynh

Assistant research professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nelly Huynh, PhD

Role: PRINCIPAL_INVESTIGATOR

Université de Montréal

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Université de Montréal

Montreal, Quebec, Canada

Site Status

Université Montpellier

Montpellier, , France

Site Status

Groupe Hospitalier Pitie-Salpetriere

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NH-14SRP-Somnyx

Identifier Type: OTHER

Identifier Source: secondary_id

14-011-CERES-D

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.